Jumat, 08 Februari 2008

FDA WARNING OF ADVERSE EFFECTS IN BOTOX AND BOTULINUM TOXIN REMINDER THAT THOUGH MILLIONS HAVE HAD WRINKLE REMOVAL SUCCESSFULLY ITS A POTENT MEDICINE

FDA WARNING OF ADVERSE EFFECTS IN BOTOX AND BOTULINUM TOXIN REMINDER THAT THOUGH MILLIONS HAVE HAD WRINKLE REMOVAL SUCCESSFULLY ITS A POTENT MEDICINE





Millions of people have had Botox injections for wrinkle removal successfully. Botulinum toxin like Botox has been used for both cosmetic and non cosmetic medical procedures such as treatment of muscle spasticity but wrinkle removal is the most popular use for botulinum toxin. Side effects of wrinkle smoothing with botulinum toxin are relatively infrequent with eyelid drooping called ptosis happening sometimes. But in a reminder that botulinum toxin is a medical compound, the FDA has issued a notice of some adverse reactions linked to Botox, Botox Cosmetic (Botulinum toxin Type A) and Myobloc (Botulinum toxin Type B). According to the FDA statement "The most severe adverse effects were found in children treated for spasticity in their limbs associated with cerebral palsy. Treatment of spasticity is not an FDA-approved use of botulism toxins in children or adults".



The FDA warning is a reminder that we are dealing with a very potent medicinal molecule. It should only be administered by qualified doctors who understand Botox and how to use it.



  • You can read about and see videos about Botox for wrinkle removal here




    Although there is no chance of contracting botulism from Botox injections, there are some risks associated with the procedure. There is a small risk of eyelid drooping (ptosis) and slight puffiness following treatment. The incidence of ptosis is about 5% but always ask your doctor what problems they have had with treatments as this will differ between doctors.

    If too much toxin is injected, for example (which has happened in the past) it can cause problems or if it is injected into the wrong facial area. Rarely, according to the drug insert, people have had allergic reactions including anaphylaxis (life threatening allergic reaction). Aminoglycoside antibiotics and other chemicals that interfere with neuromuscular transmission can interact with Botox. Pregnant women and people with neuromuscular disorders are advised to avoid Botox.




    The adverse effects in the FDA notice were found in FDA-approved and non approved usages. The most severe adverse effects were found in children treated for spasticity in their limbs associated with cerebral palsy. Treatment of spasticity is not an FDA-approved use of botulism toxins in children or adults.



  • FDA Notifies Public of Adverse Reactions Linked to Botox Use






  • Tidak ada komentar:

    Posting Komentar